Month: April 2023
Patritumab deruxtecan or HER3-DXd: A novel antibody-drug conjugate in locally advanced or metastatic non-small cell lung cancer (NSCLC) with prior EGFR TKI therapy
Patritumab deruxtecan or HER3-DXd is a novel antibody-drug conjugate that consists of a HER3 antibody attached to a topoisomerase I inhibitor payload via a cleavable…
Neuroendocine Malignancies
Neuroendocrine malignancies, are a type of cancer that develops in cells of the neuroendocrine system. The neuroendocrine system is made up of cells that produce…
Localized Prostate Cancer Treatment Study in the UK: 15-Year Follow-Up Finds Low Prostate Cancer-Specific Mortality Regardless of Treatment Assigned
The localized prostate cancer treatment study published in the New England Journal of Medicine in April 2023, conducted in the United Kingdom from 1999 to…
Lunsumio (Mosunetuzumab-axgb): A New Hope for Relapsed or Refractory Follicular Lymphoma Patients
Mosunetuzumab-axgb: A New Hope for Relapsed or Refractory Follicular Lymphoma Patients Introduction: Follicular lymphoma (FL) is a type of non-Hodgkin’s lymphoma that arises from abnormal…
New Approval by FDA for Polatuzumab Vedotin-piiq with R-CHP for Previously Untreated DLBCL: Positive Results from POLARIX Trial
The Food and Drug Administration has granted approval in April 2023 to the use of polatuzumab vedotin-piiq (Polivy, Genentech, Inc.) in combination with rituximab product,…
Frontline Treatment Options in Renal Cell Cancer
Renal cell cancer is a type of cancer that affects the kidneys, and treatment options for this condition depend on the stage of the cancer,…
How can Artificial intelligence help in medicine?
Artificial intelligence (AI) has the potential to transform medicine in many ways. The machine learning has some examples that may be helpful: Overall, AI has…
World Health Day – April 7 (Health for All)
World Health Day is an opportunity to celebrate the achievements of the global healthcare community and to promote the importance of good health for all….
Head and Neck Cancer Awareness Month – April
Head and Neck Cancer Awareness Month is observed every year in April to raise awareness about the risks, prevention, and treatment options available for this…